Found 7 matching trials
Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission
PHASE2The primary aim of this innovative immunotherapeutic study is to determine ...
Status
Active Not Recruiting
Efficacy of Dendritic Cell Therapy for Myeloid Leukemia and Myeloma
PHASE2Dendritic cell therapy is a promising strategy for adjuvant cancer therapy ...
Location
University Hospital Antwerp
Dendritic Cell Vaccination for Patients With Acute Myeloid Leukemia in Remission
PHASE1RATIONALE: Vaccines made from a patient's white blood cells (dendritic cell...
Location
Antwerp University Hospital/Center for Cellular Therapy and Regenerative Medicine
DC Vaccination for Postremission Therapy in AML
PHASE1The aim of this study is to determine the feasibility and safety of an auto...
Location
Hospital of the University of Munich, LMU; Department od Medicine III
Cellular Immunotherapy for Patients With High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia
PHASE1The main objective of this work is to conduct a clinical study for the deve...
Location
Hematology and Transfusion Medicine Center
CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
PHASE1The purpose of this study is to see if the investigator can help the immune...
Location
Memorial Sloan Kettering Cancer Center
Dendritic Cell Vaccination for Patients with Solid Tumors
PHASE1The aim of this study is to evaluate the immunogenicity and clinical effica...
Location
Antwerp University Hospital, Center for Cellular Therapy and Regenerative Medicine